Comparative responsiveness of 3 functional indices in ankylosing spondylitis

Journal of Rheumatology

Volumn 26, Issue 9, 1999, Pages 1959-1963

  Ruof, Jörg ^a,b   Sangha, Oliver ^a,c   Stucki, Gerold ^a,b  

^a Rheumaklinik und Institut fur Physikalische Medizin   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Ankylosing spondylitis; Functional index; Responsiveness

Indexed keywords

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL CAPACITY; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; SELF EVALUATION;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PATIENT SATISFACTION; PROGNOSIS; RANGE OF MOTION, ARTICULAR; RECURRENCE; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING; TREATMENT OUTCOME; VITAMIN A;

EID: 0033452832     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. van der Heijde DMFM, Bellamy N, Calin A, Dougados M, Khan MA, van der Linden S, on behalf of the Assessment in Ankylosing Spondylitis working group. Preliminary core sets for endpoints in ankylosing spondylitis. J Rheumatol 1997;24:2225-9.
2. Dougados M, Gueguen A, Nakache JP, Nguyen M, Mery C, Amor B. Evaluation of a functional index and an articular index in ankylosing spondylitis. J Rheumatol 1988;15:302-7.
3. Calin A, Garrett S, Whitelock H, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281-5.
4. Daltroy LH, Larson MG, Roberts WN, Liang MH. A modification of the Health Assessment Questionnaire for the spondylarthropathies. J Rheumatol 1990;17:946-50.
5. Ruof J, Stucki G. Comparison of the Dougados Functional Index (D-FI) and the Bath Ankylosing Spondylitis Functional Index. A literature review. J Rheumatol 1999;26:955-60.
6. Stucki G, Bachmann S, Auckenthaler C, et al. A randomized placebo-controlled trial of vitamin E and diclofenac in patients with ankylosing spondylitis [abstract]. Arthritis Rheum 1998;41 Suppl:S114.
7. Fortin PR, Stucki G, Katz JN. Measuring relevant change: an emerging challenge in rheumatologic clinical trials. Arthritis Rheum 1995;38:1027-30.
8. Liang MH, Fossel AH, Larson MG. Comparisons of five health status instruments for orthopedic evaluation. Med Care 1990;28:632-42.
9. Cohen J. Statistical power analyses for the behavioral sciences. New York: Academic Press; 1977.
10. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989;27:178-89.
11. Guyatt G, Walter S, Norman G. Measuring change over time: assessing the usefulness of evaluative instruments. J Chron Dis 1987;40:171-8.
12. Norman GR. Issues in the use of change scores in randomized trials. J Clin Epidemiol 1989;42:1097-105.
13. Stucki G, Liang MH, Fossel AH, Katz JN. Relative responsiveness of condition-specific and generic health status measures in degenerative lumbar spinal stenosis. J Clin Epidemiol 1995;48:1369-78.
14. Stucki G, Liang MH, Philipps C, Katz JN. The Short Form-36 is preferable to the SIP as a generic health status measure in patients undergoing elective total hip arthroplasty. Arthritis Care Res 1995;8:174-81.
15. Stucki G, Michel BA. How to measure improvement: rules and fallacies. Rheumatology in Europe 1995; Suppl 2:107-11.
16. SPSS Inc. SPSS Advanced Statistics. Chicago: SPSS Inc.; 1997.
17. van der Linden SM, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
18. Rosner B. Hypothesis testing: one sample inference. In: Kugushev A, editor. Fundamentals of biostatistics. Belmont: Wadsworth Publishing; 1995:191-250.